About A4I
Analysis for Innovators can help boost productivity and competitiveness in your business through solving existing problems.
A4I is a programme that gives UK businesses of any size access to cutting-edge R&D expertise and facilities to help solve problems that they have been unable to tackle using standard technologies and techniques. It might be around product reliability, cost or product lifetime.
Details of Round 5: (competitions now closed)
A4I Round 5: phase 1 expression of interest (de minimis)
A4I Round 5: phase 1 expression of interest
Impact
- 205Successful EOIs
- 303Brokerage Meetings
- 121Projects Funded
- £12.2 millionProject Costs
- £8.5 millionGovernment Contributions
- £3.7 millionCompany Contributions
Case Studies
Data Performance Consultancy Limited
DPC looks to identify social value in smart city delivery, but they had a challenge with the data, with verification and trustworthiness identified as a concern with the standard, assumed linear data being used.
IMSPEX Diagnostics Ltd
IMSPEX Diagnostics Ltd advances testing of biomethane as green energy source
Technology business IMSPEX Diagnostics Ltd partnered with NPL to advance its testing capability of biomethane. The project aimed to unlock major commercial potential for IMSPEX, drive forward European industry standards and advance the use of biogas as a renewable energy source.
Air Quality Research Ltd. (AQR)
AQR optimises clean water treatment technology
Air Quality Research Ltd. (AQR) partnered with the National Measurement Laboratory (NML), hosted at LGC, to improve the efficiency of its chemical-free and energy-saving water treatment technology, and widen its potential use in new markets.
News
Posted 26/10/2020
Paragraf and NPL Demonstrate that Paragraf’s Graphene Hall Effect Sensors are ready for High-radiation Applications in Space and Beyond
Paragraf, the leader in graphene-based transformative electronic sensors and devices, has demonstrated the ability of its graphene Hall Effect sensors to withstand high levels of radiation.
Read more
Posted 28/05/2020
Sixfold expands its portfolio of collaborative projects
Sixfold Bioscience, a biotechnology company focused on the development of drug delivery systems for gene therapeutics, has been awarded a third grant through the ‘Analysis for Innovators’ (A4I) programme co-funded by the UK’s innovation agency — Innovate UK. The project will expand the capabilities of Sixfold’s proprietary delivery systems.
Read more
Posted 18/12/2019
Sixfold Bioscience awarded two Innovate UK grants through the A4I programme
Sixfold Bioscience awarded two Innovate UK grants to advance the development of their cell and gene therapeutic delivery system.
Read more
